Peptide Atlas · Peptide

Vapreotide

Vapreotide (RC-160) is a stable somatostatin analogue with moderate-to-high affinity for somatostatin receptor subtypes 2, 3 and 5.

established

provisional
2 citations
0 discussions
0 followers
BMY 41606
RC-160
Sanvar

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Vapreotide. Tier reflects study design, not enthusiasm.
Claim	Tier	Source
Randomized trial of early vapreotide in variceal bleeding	established	pmid 11136956
RC-160 receptor subtype affinities and antiproliferative signalling	preclinical	pmid 7878022

Unanswered questions

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.